EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot study

Paul T Rosenau, Andrea Dietrich, Barbara J van den Hoofdakker, Pieter J Hoekstra

European Child & Adolescent Psychiatry · 2025

DOI: 10.1007/s00787-024-02609-1 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Child & Adolescent Psychiatry, 2025. Verfasst von Paul T Rosenau und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Lübeckweg 2, Groningen, 9723 HE, The Net…. Hauptthemen laut MEDLINE: Methylphenidate, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Attention Deficit and Disruptive Behavior Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Attention-deficit/hyperactivity (ADHD) guidelines recommend that the need for continued stimulant medication treatment of children and adolescents needs to be reviewed at least annually. We aimed to assess the outcomes in clinical practice of placebo-controlled discontinuation trials after long-term methylphenidate treatment. We asked clinicians to implement N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials after at least one year of methylphenidate treatment of children and adolescents (n = 26, 6-15 years of age). We analyzed the effectiveness of ongoing methylphenidate treatment compared to placebo on symptoms of ADHD, oppositional defiant disorder, and conduct disorder according to both parents and teachers, and the global improvement or deterioration according to the clinicians. We also assessed the proportion of individuals who continued using methylphenidate after the discontinuation trial. Teacher-rated hyperactivity and impulsivity symptoms were significantly lower during methylphenidate treatment compared to placebo (β = 3.80, SD = 1.69, t = 2.25, p =.04). No other significant differences were found between methylphenidate and placebo. Almost two-thirds (n = 16, 61.5%) of individuals continued using methylphenidate after the discontinuation trials, of which seven did not deteriorate during placebo according to their clinician. Our findings support the need for regular evaluations of methylphenidate treatment effectiveness and emphasize the importance of including the school setting when evaluating treatments. Better guidance for clinicians when to continue or cease methylphenidate treatment is urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylphenidateAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsAttention Deficit and Disruptive Behavior DisordersHumansChildDouble-Blind MethodCross-Over StudiesMaleAdolescentPilot ProjectsFemaleTreatment OutcomeConduct Disorder

Stichwörter der Autor:innen

ADHDDiscontinuation trialMethylphenidateTreatment monitoring

Substanzen

MethylphenidateCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Lübeckweg 2, Groningen, 9723 HE, The Netherlands. p.rosenau@accare.nl.
  • Accare Child Study Center, Groningen, The Netherlands. p.rosenau@accare.nl.
  • The Research School of Behavioural and Cognitive Neurosciences, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands. p.rosenau@accare.nl.
  • Department of Child and Adolescent Psychiatry, University of Groningen, University Medical Center Groningen, Lübeckweg 2, Groningen, 9723 HE, The Netherlands.
  • Accare Child Study Center, Groningen, The Netherlands.
  • The Research School of Behavioural and Cognitive Neurosciences, University of Groningen, Ant. Deusinglaan 1, Groningen, 9713 AV, The Netherlands.

Förderung

  • ZonMw

Zitieren

APA

Rosenau, P. T., Dietrich, A., van den Hoofdakker, B. J., & Hoekstra, P. J. (2025). Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot study. European Child & Adolescent Psychiatry. https://doi.org/10.1007/s00787-024-02609-1

Vancouver

Rosenau PT, Dietrich A, van den Hoofdakker BJ, Hoekstra PJ. Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot study. European Child & Adolescent Psychiatry. 2025. doi:10.1007/s00787-024-02609-1

BibTeX
@article{Rosenau2025,
  author = {Rosenau, Paul T and Dietrich, Andrea and van den Hoofdakker, Barbara J and Hoekstra, Pieter J},
  title = {Results of N = 1 randomized, double-blind, placebo-controlled, cross-over discontinuation trials embedded in clinical practice after longer term methylphenidate use: a pilot study},
  journal = {European Child & Adolescent Psychiatry},
  year = {2025},
  doi = {10.1007/s00787-024-02609-1}
}
Kostenlos starten →